NCT04107740 - C-Trelin Orally Disintegrated(OD) Tablet 5mg in Ataxia Due to Spinocerebellar Degeneration | Biotech Hunter

Enrollment

160

Participants

Timeline

Start Date

March 4, 2019

Primary Completion Date

February 8, 2021

Study Completion Date

February 8, 2021

Conditions

Spinocerebellar Degeneration

Interventions

DRUG

C-Trelin OD Tab(5mg Taltirelin Hydrate)

BID, 10mg per day, for 24 weeks

DRUG

Placebo

BID, 10mg per day, for 24 weeks

Trial Locations (8)

Chonnam National University Hospital, Gwangju

Gangnam Severance Hospital, Seoul

Korea University Anam Hospital, Seoul

Korea University Guro Hospital, Seoul

Samsung Medical Center, Seoul

Seoul Metropolitan Government Seoul National University Boramae Medical Center, Seoul

Seoul National University Hospital, Seoul

The Catholic University of Korea, Seoul ST. Mary's Hospital, Seoul